Quick Answer
Rani Therapeutics Holdings, Inc. reported Total Revenue of $1.63 million for fiscal year 2025.
Rani Therapeutics Holdings, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $1.63M | +58.9% |
| 2024 | $1.03M | — |
| 2023 | $0.00 | — |
| 2022 | $0.00 | -100.0% |
| 2021 | $2.72M | +488.1% |
| 2020 | $462.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | — | -100.0% |
| March 31, 2025 | $172.0K | — | — |
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | — | — |
| September 30, 2022 | $0.00 | — | — |
| June 30, 2022 | $0.00 | -100.0% | — |
- Rani Therapeutics Holdings, Inc. showed an increase of +58.9% in Total Revenue compared to the prior fiscal year.
- Over the 2020–2025 period, Rani Therapeutics Holdings, Inc.’s total revenue has grown by 253.5% (from $462.0 thousand to $1.63 million).
- The most recent figure is from Rani Therapeutics Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: